AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Circa Group AS

Regulatory Filings Feb 28, 2023

3570_rns_2023-02-28_cbfd9389-50dd-4d15-a2b7-097959e41809.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

CIRCA AND EKATO SIGN STRATEGIC TECHNOLOGY AGREEMENT

CIRCA AND EKATO SIGN STRATEGIC TECHNOLOGY AGREEMENT

OSLO, NORWAY – 28 FEBRUARY 2023 – Circa Group AS (stock symbol: CIRCA) today announced a strategic technology partnership with EKATO.

The agreement that has been signed with EKATO will see Circa incorporate EKATO’s hydrogenation technology in the development of its ReSolute plant, which will be commissioned in June 2024. The partnership also covers future commercial scale plants including FC6, which is in the planning stages.

EKATO Group is the market leader in hydrogenation technology, which plays a critical role in the production of Cyrene™, Circa’s flagship bio-based solvent.

EKATO RMT GmbH CEO Philip Mathon said: “At EKATO, we have a great strategic interest to cooperate with companies developing innovative processes for production of bio-based chemicals and materials. This long-term cooperation agreement with CIRCA, is therefore, very important to us. As the leading process loop solution provider in hydrogenation technology, we contribute with our long-standing know-how and expertise from engineering to equipment to process solution so as to ensure that CIRCA’s production process captures the synergies of sustainability and profit.”

Circa Group AS CEO Tony Duncan said “Our contracts with major vendors are a significant milestone as we progress towards the commissioning of ReSolute. By partnering with global leaders of the chemical industry like EKATO, Circa is gaining access to high calibre skills and the latest technology. This strategic partnership positions Circa to work with the best in the field, as we execute our vision to produce 80,000 tonnes of Cyrene™ by 2030.”

About Circa

Established in 2006, Circa Group converts sustainable, non-food biomass into advanced bio-based chemicals with its proprietary Furacell™ process. Its developing product portfolio includes flavours, biopolymers, and bio-solvents including Cyrene™. By creating renewable chemicals from cellulose, Circa is extracting value from non-food biomass and addressing a gap in the market by providing bio-based, less carbon intensive alternatives, contributing to a more circular economy.

https://circa-group.com

Investor Contact

Tone Leivestad

Chief Financial Officer

Circa Group AS

[email protected]

Tel: +47 406 39 455

Media Contact

Amanda Keogh

General Manager Marketing and Sustainability

Circa Group AS

[email protected]

Tel: +61 407 275 126

Talk to a Data Expert

Have a question? We'll get back to you promptly.